Comparing practice patterns and outcomes for early-stage hormone receptor-positive and node-positive breast cancer patients with high-intermediate-risk Oncotype Dx scores in the National Cancer Database.

Keerthi Tamragouri,Ethan M. Ritz,Ruta D. Rao,Cristina ODonoghue

Comparing practice patterns and outcomes for early-stage hormone receptor-positive and node-positive breast cancer patients with high-intermediate-risk Oncotype Dx scores in the National Cancer Database.

2021

Keerthi Tamragouri
Ethan M. Ritz
Ruta D. Rao
Cristina ODonoghue

e12520Background: Oncotype Dx (ODX) is a commercial diagnostic test primarily used to predict the likely benefit from chemotherapy in ER+, HER2-, and node negative breast cancer. The prognostic val...

Keywords:

Medicine
Oncotype DX
Internal medicine
practice patterns
Oncology
Chemotherapy
Cancer
Hormone receptor
high intermediate risk
Stage (cooking)
Breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations